# Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

> **NCT00848549** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 295 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Zonisamide
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT00848549
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-06
- **Final completion:** 2011-11
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2015-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00848549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00848549, "Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00848549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*